Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
Currently Operating in One Region
Press Mentions

October 17, 2015
Why Peter Thiel Invested In New York Biotech Startup EpiBone
EpiBone uses stem cells to regrow damaged bones. After getting a PhD from Columbia, Nina Tandon returned to school for an MBA to form a company at the forefront of 'biology as design.'
Read on Inc.com »More Ventures in Health
Get the Unreasonable Newsletter
Get twice-monthly updates on EpiBone and over 349 other ventures working to solve the world's toughest problems.